Pathology News Roundup: February 28, 2025

CAP Pushes HHS to Revoke FDA LDT Regulation. The College of American Pathologists (CAP) is calling on the Department of Health and Human Services (HHS) to terminate the laboratory-developed test (LDT) oversight regulation by the Food and Drug Administration (FDA).

The CAP has opposed the FDA rulemaking and advocated for the administration to rescind the rulemaking by citing significant concerns over extraordinary costs and regulatory burdens on laboratories.  

“After the FDA proposed and finalized its rulemaking on the oversight of LDTs, pathologists and their laboratories objected to the arbitrariness and significant costs the new rule imposed on the development of these lifesaving tests,” said CAP President Donald Karcher, MD, FCAP. “Now is the time for the FDA to pull back a regulation that adversely impacts laboratories and their ability to develop and provide these innovative tests for our patients. We urge the administration to act before the first stage of the rulemaking takes effect on May 6.” 

President Trump signed the executive order Unleashing Prosperity Through Deregulation on January 31 to eliminate unnecessary regulatory burdens. The FDA LDT oversight rulemaking continues to cause laboratories to reevaluate the LDTs they can offer to patients. The CAP has urged the administration to rescind the rulemaking in a February 14 letter to new HHS Secretary Robert Kennedy and a January 21 communication to President Trump’s transition team. 

USCAP 2025. It's almost March -- and that means it's almost time for the The United States and Canadian Academy of Pathology (USCAP) Annual Meeting.

USCAP 2025 is the world's largest gathering of pathologists, offering a platform for professionals to engage with groundbreaking research, learn from esteemed experts, and network with peers. The 2025 meeting is scheduled for March 22–27 at the Boston Convention and Exhibition Center in Boston, MA. 

Pathologists attending this event can benefit from a diverse array of educational opportunities, including:

• Lectures by Renowned Experts: Sessions such as the Maude Abbott Lecture and Timely Topics Lecture provide insights into the latest advancements in pathology. 
• Specialized Courses: Offerings like the Long Course delve into specific areas, enhancing both knowledge and practical skills. The 2025 Long Course will examine a variety of non-neoplastic and neoplastic diseases of the bones and joints, as well as a spectrum of soft tissue neoplasms.
• Networking Opportunities: The meeting facilitates connections with colleagues, potential collaborators, and leaders in the field, fostering professional growth and collaboration. 

For more details and registration information, visit the official USCAP Annual Meeting website.

AI Features Webinar. You're invited to check out the latest AI innovations in VoiceOver PRO, in an upcoming live webinar hosted by Voicebrook's Client Engagement Team. 

Join Voicebrook on March 19, 2025 at 3:00 p.m. EST for an overview of AI Features in VoiceOver PRO. PRO's suite of AI-powered features exemplifies Voicebrook's commitment to providing innovative solutions that streamline workflows, reduce errors, and enhance reporting accuracy—all while adapting to the real-world needs of pathologists and laboratory staff. 

In this webinar, you'll get to see some of these Generative AI features in action, including DraftDiagnosis, Draft Procedure Line, and No Pause Biopsy.

Register online to join the webinar on March 19.